Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 132

PubMed (Weighted) Links for Protein (Select 4502673)

1.

CD47 protein expression in acute myeloid leukemia: A tissue microarray-based analysis.

Galli S, Zlobec I, Schürch C, Perren A, Ochsenbein AF, Banz Y.

Leuk Res. 2015 Jul;39(7):749-56. doi: 10.1016/j.leukres.2015.04.007. Epub 2015 Apr 20.

PMID:
25943033
2.

Alternative 3' UTRs act as scaffolds to regulate membrane protein localization.

Berkovits BD, Mayr C.

Nature. 2015 Jun 18;522(7556):363-7. doi: 10.1038/nature14321. Epub 2015 Apr 20.

PMID:
25896326
3.

CD47 signaling regulates the immunosuppressive activity of VEGF in T cells.

Kaur S, Chang T, Singh SP, Lim L, Mannan P, Garfield SH, Pendrak ML, Soto-Pantoja DR, Rosenberg AZ, Jin S, Roberts DD.

J Immunol. 2014 Oct 15;193(8):3914-24. doi: 10.4049/jimmunol.1303116. Epub 2014 Sep 8.

PMID:
25200950
4.

Ligation of CD47 induces G1 arrest in EBV-transformed B cells through ROS generation, p38 MAPK/JNK activation, and Tap73 upregulation.

Park GB, Bang SR, Lee HK, Kim D, Kim S, Kim JK, Kim YS, Hur DY.

J Immunother. 2014 Jul-Aug;37(6):309-20. doi: 10.1097/CJI.0000000000000042.

PMID:
24911792
5.

CD47-dependent immunomodulatory and angiogenic activities of extracellular vesicles produced by T cells.

Kaur S, Singh SP, Elkahloun AG, Wu W, Abu-Asab MS, Roberts DD.

Matrix Biol. 2014 Jul;37:49-59. doi: 10.1016/j.matbio.2014.05.007. Epub 2014 Jun 2.

6.

Intravenous delivery of siRNA targeting CD47 effectively inhibits melanoma tumor growth and lung metastasis.

Wang Y, Xu Z, Guo S, Zhang L, Sharma A, Robertson GP, Huang L.

Mol Ther. 2013 Oct;21(10):1919-29. doi: 10.1038/mt.2013.135. Epub 2013 Jun 18.

7.

Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response.

Tseng D, Volkmer JP, Willingham SB, Contreras-Trujillo H, Fathman JW, Fernhoff NB, Seita J, Inlay MA, Weiskopf K, Miyanishi M, Weissman IL.

Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):11103-8. doi: 10.1073/pnas.1305569110. Epub 2013 May 20.

8.

CD47 is expressed abnormally on hematopoietic cells in myelodysplastic syndrome.

Jiang H, Fu R, Wang H, Li L, Liu H, Shao Z.

Leuk Res. 2013 Aug;37(8):907-10. doi: 10.1016/j.leukres.2013.04.008. Epub 2013 May 2.

PMID:
23642736
9.

Association study identifying polymorphisms in CD47 and other extracellular matrix pathway genes as putative prognostic markers for colorectal cancer.

Lascorz J, Bevier M, V Schönfels W, Kalthoff H, Aselmann H, Beckmann J, Egberts J, Buch S, Becker T, Schreiber S, Hampe J, Hemminki K, Schafmayer C, Försti A.

Int J Colorectal Dis. 2013 Feb;28(2):173-81. doi: 10.1007/s00384-012-1541-4. Epub 2012 Jul 28.

PMID:
23011546
10.

Engulfment of hematopoietic stem cells caused by down-regulation of CD47 is critical in the pathogenesis of hemophagocytic lymphohistiocytosis.

Kuriyama T, Takenaka K, Kohno K, Yamauchi T, Daitoku S, Yoshimoto G, Kikushige Y, Kishimoto J, Abe Y, Harada N, Miyamoto T, Iwasaki H, Teshima T, Akashi K.

Blood. 2012 Nov 8;120(19):4058-67. doi: 10.1182/blood-2012-02-408864. Epub 2012 Sep 18.

11.

CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma.

Suzuki S, Yokobori T, Tanaka N, Sakai M, Sano A, Inose T, Sohda M, Nakajima M, Miyazaki T, Kato H, Kuwano H.

Oncol Rep. 2012 Aug;28(2):465-72. doi: 10.3892/or.2012.1831. Epub 2012 May 24.

PMID:
22641236
12.

CD47 functions as a molecular switch for erythrocyte phagocytosis.

Burger P, Hilarius-Stokman P, de Korte D, van den Berg TK, van Bruggen R.

Blood. 2012 Jun 7;119(23):5512-21. doi: 10.1182/blood-2011-10-386805. Epub 2012 Mar 16.

13.

Integrin-associated protein (CD47) is a putative mediator for soluble fibrinogen interaction with human red blood cells membrane.

De Oliveira S, Vitorino de Almeida V, Calado A, Rosário HS, Saldanha C.

Biochim Biophys Acta. 2012 Mar;1818(3):481-90. doi: 10.1016/j.bbamem.2011.10.028. Epub 2011 Nov 4.

14.

The CD47 pathway is deregulated in human immune thrombocytopenia.

Catani L, Sollazzo D, Ricci F, Polverelli N, Palandri F, Baccarani M, Vianelli N, Lemoli RM.

Exp Hematol. 2011 Apr;39(4):486-94. doi: 10.1016/j.exphem.2010.12.011. Epub 2011 Jan 4.

PMID:
21211546
15.

MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47.

Junker A, Krumbholz M, Eisele S, Mohan H, Augstein F, Bittner R, Lassmann H, Wekerle H, Hohlfeld R, Meinl E.

Brain. 2009 Dec;132(Pt 12):3342-52. doi: 10.1093/brain/awp300. Epub .

16.

Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47.

Hatherley D, Graham SC, Turner J, Harlos K, Stuart DI, Barclay AN.

Mol Cell. 2008 Jul 25;31(2):266-77. doi: 10.1016/j.molcel.2008.05.026.

17.

Association of CD47 with natural killer cell-mediated cytotoxicity of head-and-neck squamous cell carcinoma lines.

Kim MJ, Lee JC, Lee JJ, Kim S, Lee SG, Park SW, Sung MW, Heo DS.

Tumour Biol. 2008;29(1):28-34. doi: 10.1159/000132568. Epub 2008 May 23.

PMID:
18497546
18.

Apoptosis inducing bivalent single-chain antibody fragments against CD47 showed antitumor potency for multiple myeloma.

Kikuchi Y, Uno S, Kinoshita Y, Yoshimura Y, Iida S, Wakahara Y, Tsuchiya M, Yamada-Okabe H, Fukushima N.

Leuk Res. 2005 Apr;29(4):445-50. Epub 2004 Dec 18.

PMID:
15725479
19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk